AWS
ABBV icon

Aspen Wealth Strategies’s AbbVie ABBV Stock Holding History

Aspen Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
10,224
+412
+4% +$88.6K 1.24% 20
2026
Q1 		$2.13M Sell
9,812
-54
-0.5% -$12K 1.14% 20
2025
Q4 		$2.25M Sell
9,866
-28
-0.3% -$6.38K 1.23% 20
2025
Q3 		$2.29M Buy
9,894
+99
+1% +$20.2K 1.27% 16
2025
Q2 		$1.82M Sell
9,795
-382
-4% -$71K 1.1% 18
2025
Q1 		$2.13M Sell
10,177
-129
-1% -$25.1K 1.4% 15
2024
Q4 		$1.83M Buy
10,306
+277
+3% +$50.9K 1.17% 15
2024
Q3 		$1.98M Sell
10,029
-615
-6% -$115K 1.28% 12
2024
Q2 		$1.87M Sell
10,644
-100
-0.9% -$16.6K 1.3% 12
2024
Q1 		$1.96M Sell
10,744
-719
-6% -$124K 1.35% 13
2023
Q4 		$1.78M Buy
11,463
+61
+0.5% +$8.89K 1.29% 15
2023
Q3 		$1.7M Buy
11,402
+164
+1% +$24.1K 1.33% 14
2023
Q2 		$1.51M Sell
11,238
-556
-5% -$81.5K 1.15% 13
2023
Q1 		$1.88M Sell
11,794
-205
-2% -$31.3K 1.46% 13
2022
Q4 		$1.94M Buy
+11,999
New +$1.84M 1.55% 12

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aspen Wealth Strategies's ABBV Position: Q2 2026 in Review

Aspen Wealth Strategies increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $88.6K and bringing the position to 10,224 shares worth $2.57M. The position accounts for 1.24% of the portfolio, ranked #20.

Aspen Wealth Strategies first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aspen Wealth Strategies held 10,224 shares of AbbVie worth $2.57M as of Q2 2026.
  • Aspen Wealth Strategies bought 412 AbbVie shares in Q2 2026, an estimated $88.6K.
  • AbbVie made up 1.24% of Aspen Wealth Strategies's portfolio in Q2 2026, its #20 holding.
  • Aspen Wealth Strategies first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aspen Wealth Strategies's 13F filing for Q2 2026, filed 7 Aug 2026.